In this study, the programmable TDF nanoplatform integrating multiple functionalities including kidney‐targeting module, NIR fluorescence module, and Kim‐1‐targeting module allows real‐time tracking of the dynamic variation of in situ Kim‐1, which can be used to diagnose AKI at the early stage. This evidence concerns the gene HAVCR1 and acute kidney injury.